For the Media
Dr. Aude Chapuis is a member of Fred Hutch's Clinical Research Division and is a researcher in the Program in Immunology. Her focus is understanding the factors associated with successful adoptive transfer of immune T cells and improving the outcomes, developing methods that improve the survival, proliferation and anti-tumor activity of infused T-cell products so as to better eliminate tumor targets and clinical strategies to optimally activate T cells in humans. Chapuis is also an attending physician with the Fred Hutch Bone Marrow Transplant Program at the Seattle Cancer Care Alliance.
Overview of Aude Chapuis' Research Focus
Developing novel ways to modulate the immune system to target cancer.
Aude Chapuis - Brief Curriculum Vitae
Appointments, affiliations and researcher interests
Program in Immunology
Researchers are learning how to empower a patient’s own immune system to do what it does naturally — fight disease. They continue discovering new ways to give the immune cell army the upper hand against cancer and learning how immune cells respond to disease and how to safely enhance immune responses to better control, cure and potentially prevent cancers and other serious diseases.
Clinical Research Division
Researchers conduct laboratory and patient-oriented research to better understand the mechanisms that drive cancer and other human diseases. Integrating a variety of disciplines, our investigators are continually developing new therapeutic approaches and leading clinical trials that help move discoveries from laboratory to patient. Our pioneering research has saved hundreds of thousands of lives.
At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first National Cancer Institute-funded cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.